Azacitidine Injection Clinical Trials
4 recruitingDrug
Phase 22Phase 32
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
Acute Myeloid Leukemia
Ascentage Pharma Group Inc.486 enrolled6 locationsNCT06389292
Recruiting
Phase 3
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Ascentage Pharma Group Inc.490 enrolled2 locationsNCT06641414
Recruiting
Phase 2
Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
Relapse/RecurrenceAML, ChildhoodRefractory AML+2 more
Children's Hospital of Soochow University50 enrolled12 locationsNCT06316960
Recruiting
Phase 2
Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML
Acute Myeloid Leukemia
Ludwig-Maximilians - University of Munich30 enrolled1 locationNCT04913922